Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent pembrolizumab.

Saltman, David L; Nielsen, Tyler J; Salina, Davide; Hout, David R; McMahon, Frank B; Valev, Boris R; Huk, Michael; Chandra, Pranil K; Spille, Jeremy; Seitz, Robert S; Schweitzer, Brock L

Saltman, David L; Nielsen, Tyler J; Salina, Davide; Hout, David R; McMahon, Frank B; Valev, Boris R; Huk, Michael; Chandra, Pranil K; Spille, Jeremy; Seitz, Robert S; Schweitzer, Brock L.

Afiliação

Saltman DL; BC Cancer, 2410 Lee Avenue, Victoria, BC V8R 6V5, Canada.
Nielsen TJ; Oncocyte Corporation, Irvine, CA, USA.
Salina D; Department of Laboratory Medicine, Royal Jubilee Hospital, Victoria, BC, Canada.
Hout DR; Oncocyte Corporation, Irvine, CA, USA.
McMahon FB; Oncocyte Corporation, Irvine, CA, USA.
Valev BR; BC Cancer, Victoria, BC, Canada.
Huk M; Department of Medical Imaging, Royal Jubilee Hospital, Victoria, BC, Canada.
Chandra PK; PathGroup, Nashville, TN, USA.
Spille J; Oncocyte Corporation, Irvine, CA, USA.
Seitz RS; Oncocyte Corporation, Irvine, CA, USA.
Schweitzer BL; Oncocyte Corporation, Irvine, CA, USA.

Ther Adv Med Oncol ; 13: 17588359211010156, 2021.

Article em En | MEDLINE | ID: mdl-33953802

Palavras-chave

immune checkpoint inhibitor; lung cancer; pancreas; programmed death ligand 1; tumor immune-microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article